Physician profile
Benjamin J Lee
NPI 1053745943
$1,420.16
in general payments reported to CMS, 2019-2025
20 companies · $57.97 in 2025
The $57.97 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $122 · 2021: $48.64 · 2022: $441 · 2023: $489 · 2024: $54.87 · 2025: $57.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $264.53 | 2019-2023 | Farxiga |
| Abbvie INC. | $206.10 | 2023 | |
| Boston Scientific Corporation | $170.65 | 2020-2023 | Varithena Administration Pack |
| Pfizer INC. | $138.13 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $101.06 | 2019-2023 | |
| Amgen INC. | $90.34 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $84.12 | 2019-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.90 | 2023-2024 | Jardiance |
| Amarin Pharma, INC. | $45.32 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.33 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $31.28 | 2021 | |
| Philips North America LLC | $28.27 | 2022-2025 | Event |
| Merck Sharp & Dohme LLC | $25.99 | 2023 | Verquvo |
| Novo Nordisk INC | $24.62 | 2022 | |
| Chiesi USA, INC. | $23.48 | 2025 | Juxtapid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $23.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.36 | 2021 | |
| Impulse Dynamics (USA) INC. | $17.25 | 2023 | Optimizer |
| Irhythm Technologies, INC. | $12.36 | 2020 | |
| Organon LLC | $4.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.